Skip to the page

Data / Form D filings / BioMotiv, LLC

BioMotiv, LLC: Form D filings

BioMotiv, LLC, a biotechnology company in Cleveland, OH, filed 7 Form D notices with the SEC between 2012 and 2018. The latest, on August 1, 2018, reports $145.7 million sold of a $200 million offering to 62 investors.

Find out what BioMotiv, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
20600 CHAGRIN BLVD., SUITE 210, Cleveland, OH, 44122
Phone
(216) 455-3216
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1557499

The full lists. Form D filings in Ohio: 1,071 rows, $53.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 1, 2018Amendment$200,000,000$145,726,790$54,273,21062Aug 22, 2012sec.gov
Aug 4, 2017Amendment$200,000,000$145,726,790$54,273,21062Aug 22, 2012sec.gov
Aug 5, 2016Amendment$200,000,000$144,676,790$55,323,21062Aug 22, 2012sec.gov
Aug 6, 2015Amendment$150,000,000$81,426,790$68,573,21057Aug 22, 2012sec.gov
Aug 7, 2014Amendment$100,000,000$50,976,790$49,023,21054Aug 22, 2012sec.gov
Aug 6, 2013Amendment$100,000,000$46,194,555$53,805,44547Aug 22, 2012sec.gov
Sep 5, 2012New notice$100,000,000$21,000,000$79,000,0002Aug 22, 2012sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Mark S. TeagueExecutive Officer
Jeffrey S. Edelson, MDExecutive Officer
Carmen S. Bozic, MDDirector
Stacie S. SwitzerExecutive Officer
Baiju R. ShahExecutive Officer, Director
Terry S. VanceExecutive Officer
Robert S. ReitmanDirector
David C. U'Prichard, Ph.D.Director
Charles S. McOsker, Ph.D.Executive Officer
Ronald G. HarringtonDirector
Jonathan S. Stamler, M.D.Director
Michael S. Martin, Ph.D.Director
Theodore S. Torphy, Ph.D.Executive Officer

Other biotechnology companies in Ohio that filed recently

Every Form D from the week of Jul 30, 2018 · All recent filings in Ohio · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what BioMotiv, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.